Heroes of Chemistry Archive

A listing of ACS Heroes of Chemistry award recipients prior to 2023.

  • 2022 Recipients

    3M: RelyX™

    Unicem and Universal Dental Cements provide outstanding high performance in oral environments, significant handling advantages, simpler dental workflows and virtually no post-operative sensitivities.

    Awardees: Reinhold Hecht, Joel Oxman, Gioacchino Raia, Christoph Thalacker, Henry Loll,  Roman Eberle, Andrea Stippschild-Boxler, Kai Uwe Claussen, Markus Mikulla, Peter Bissinger, Wolf Steiger, Andrea Hailand, Michael Sogl, Manfred Ludsteck, Hubert Rennschmid, and Rainer Guggenberger


    Elite™ and Innate™ are precise, on-demand, molecularly tailored, enhanced polyethylenes to meet a range of packaging requirements.

    Awardees: Anthony Castelluccio, Dr. Pak-Wing Steve Chum, Jackie deGroot, Tim Gambrel, Frederick Gemoets, Douglas Ginger, Suzanne Guerra, Lonnie Hazlitt, Dr. Carl Iverson, Pradeep Jain, Dr. Mridula (Babli) Kapur, Wayde Konze, Ed Madenjian, Jesús Nieto, Dr. Rajen Patel, and Dr. Jiang Wang,

    Eli Lilly and Company

    Verzenio® (abemaciclib) is a selective CDK4 and CDK6 inhibitor for the treatment of both advanced and metastatic, as well as high-risk early breast cancers.

    Awardees: Dr. Alfonso de Dios, Dr. Concepción Sánchez-Martínez, Dr. María José Lallena, Dr. Carlos Pérez, Dr. Miriam del Prado, Dr. Raquel Torres, Dr. Mike Frederick, Dr. Aktham Aburub, Dr. Larry Gelbert, Dr. Emiko Kreklau, Dr. Graham Wishart, Shobba Battachar, and Dr. Katie Heinz-Taheny

    Merck and Co. Inc., Ridgeback Therapeutics and Emory University

    Lagevrio™ (molnupiravir) is a novel antiviral for the treatment of COVID-19. It was granted emergency use authorization by the U.S. Food and Drug Administration.

    Awardees:  George Painter, Michael Natchus, Gregory Bluemling, Alexander Kolykhalov, Manohar Saindane, Damien Kuiper, William Morris, Patrick Fier, Jameson Bothe, Lushi Tan, Yingju Xu, Frank Bernardoni, Mike Ward, Darryl Chang, Michael Lowinger, Grace Okoh, Christopher Neu, Abraham Woldu, Andrew Brunskill, Sanjaykumar Patel, and Colette McMahon


    mRNA-1273 SARS-CoV-2 Vaccine (Spikevax™) is an mRNA vaccine against COVID-19, authorized by the Food and Drug Administration for individuals 18 years of age and older.

    Awardees: Kerry Benenato, Gabor Butora, Sathyajith Kumarasinghe, Jim Lim, and Greg Mercer


    Paxlovid™ is a medicine granted emergency use authorization by the Food and Drug Administration for the treatment of mild to moderate COVID-19.

    Awardees: Matthew Reese, Melissa Avery, Patrick R Verhoest, Christophe Allais, Hugh Clarke, Karen Coffman, Charlotte Allerton, Eric Cordi,  Jamison Tuttle, Jared Piper, Jisun Lee, Joy (Qingyi) Yang, Kevin Ogilvie, Samir Kulkarni, Taegyo Lee,  Liuqing Wei, Martin Pettersson, Matthew Sammons, Emma McInturff, Paul Meenan, Nga Do, David Place, John Ragan, Dafydd Owen, Matt Weekly, and Xiaojing (Helen) Yang




  • 2021 Recipients


    The American Chemical Society honors scientists from 3M for the development of Tegaderm™ CHG Antimicrobial Dressing Platform, a catheter securement dressing containing an antimicrobial agent to help reduce CRBSI risks. 

    Awardees: Bob Asmus, Dan Duan, Jim Dizio, Don Peterson, Dan Popko, Maria Ruiz, Deb Schwab, Terry Smorch, George Zhicheng Tian, Kheng Vang, Ying Zhang


    The American Chemical Society honors scientists from AbbVie for the development of VENCLEXTA®/VENCLYXTO® (venetoclax), a first-in-class medicine that selectively binds/inhibits the B-cell lymphoma-2 (BCL-2) protein, and is approved for certain blood cancer treatments.

    Awardees: Andrew Souers, Aaron Kunzer, Gerald Sullivan, Hong Ding, Lisa Hasvold, Le Wang, Michael Wendt, Milan Bruncko, Xiaohong Song, Xilu Wang, Zhi-Fu Tao, Steven Elmore, Chang Park, Cheol-Min Park, Saul Rosenberg, Yi-Yin Ku, Vincent Chan, Timothy Grieme, Alan Christesen, Mathew Mulhern, Yu-Ming Pu

    AstraZeneca/Bristol Meyers Squibb

    The American Chemical Society honors scientists from AstraZeneca and Bristol Meyers Squibb for the development of Farxiga (dapagliflozin), a C-aryl glucoside SGLT2 inhibitor that reduces hyperglycemia, sodium reabsorption, body weight and blood pressure while increasing hematocrit and providing cardiac and renal benefits.

    Awardees: Elisabeth Björk, David Boulton, Prashant Deshpande, Bruce Ellsworth, Karen From, Nayyar Iqbal, Anna Maria Langkilde, Per Lindblom, Peggy McCann, Wei Meng, Daniele Paone, Phil Sher, Bill Washburn, Gang Wu


    The American Chemical Society honors scientists from Merck for the development of KEYTRUDA® (pembrolizumab) a humanized monoclonal antibody that targets PD-1 for the treatment of cancer. 

    Awardees: Marc Bastiaansen, Parimal R Desai, Stephen Farran, Kevin Gurney, Brad Holstine, Beth Junker, Sunitha Kandula, Thomas Linden, Nguyen Ly, Gargi Maheshwari, Athena Nagi, Chakravarthy Narasimhan, Dennis Rendeiro, Daisy Richardson, David Roush, Patricia Rowicki, Mohammed Shameem, Manoj Sharma, Markus Tanner, Scott Tobler, Nihal Tugcu


    The American Chemical Society honors scientists from Novartis for the development of ENTRESTO® (sacubitril/valsartan) is an angiotensin receptor neprilysin inhibitor (ARNI) delivering concomitant neprilysin inhibition and blockage of the angiotensin II type-1 receptor, approved to reduce the risk of cardiovascular death and heart failure (HF) hospitalization in adults with chronic HF.

    Awardees: Thomas Blacklock, Reynalda DeJesus, Clive Diefenbacher, Lili Feng, Michael Girgis, Sven Godtfredsen, Bin Hu, Piotr Karpinski, Gary Ksander, Yugang Liu, Mahavir Prashad, Paul Sutton, Andrew Yuan


    The American Chemical Society honors scientists from Pfizer for the development of LORBRENA is a third-generation ALK inhibitor specifically designed by Pfizer scientists to inhibit the most common tumor mutations that drive resistance to current medications and to address metastases in the brain. It was first approved in 2018 for people with previously treated ALK-positive NSCLC, and in 2021 received an expanded approval for those newly diagnosed with the disease.

    Awardees: Paul Richardson, Bob Dugger, Michael Collin, Simon Bailey, Judith Deal, Sebateen Monfette, Peter Qinhua Huang, Bryan Li, Mingying He, John Kath, Ted Johnson, Michele Mctigue, Peter Rose, Robert Kania, J. Jean Cui, Robert Hoffman, Cindy Palmer, Phuong Le, Ben Burke

  • 2020 Recipients

    AST Products, Inc.

    The American Chemical Society honors scientists from AST Products, Inc. for the development of LubriMATRIX™, a surface treatment for intraocular lens injectors.

    Awardee: William Lee


    The American Chemical Society honors scientists from DuPont for the development of FilmTec™, a reverse osmosis technology that employs a membrane liquid separation process to reject dissolved solutes on a nanoscale level.

    Awardees: Tina Arrowood, Steven Jons, Steve Rosenberg


    The American Chemical Society honors scientists from DuPont for the development of Chemical Mechanical Planarization (CMP), a key process in semiconductor fabrication, which supplies the advanced chips needed for smartphones, computing, the internet of things, vehicles and numerous industrial applications.

    Awardees: William Budinger, Marty DeGroot, David James, MaryJo Kulp, Harry George McClain, Bainian Qian, John Roberts

    Janssen Pharmaceutical Companies of Johnson & Johnson

    The American Chemical Society honors scientists from Janssen Pharmaceutical Companies of Johnson & Johnson for the development of SIRTURO® (bedaquiline), the first treatment with a novel mechanism of action against tuberculosis (TB).

    Awardees: Koen Andries, Jerome Guillemont, Anil Koul

  • 2019 Recipients


    The American Chemical Society honors scientists from DuPont for the development of Cyrel® EASY, an advanced flexographic printing plate technology platform. Cyrel® EASY is part of an ongoing effort to drive advancement in the flexographic printing industry by improving print quality, consistency, sustainability, and productivity.

    Awardees: Robert Blomquist, Mark Hackler, Adrian Lungu, Violeta Lungu, Rajgopal Subramanian

    Paratek Pharmaceuticals

    The American Chemical Society acknowledges the many who contributed to the chemistry and the medical and clinical development that brought omadacycline, trade name NUZYRA®, and sarecycline, trade name SEYSARA®, to market.

    NUZYRA® is a once-daily broad-spectrum oral and intravenous antibiotic for the treatment of adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). SEYSARA® is a once-daily narrow-spectrum oral antibiotic for the treatment of moderate to severe acne vulgaris.

    Awardees: Paul Abato, Haregewein Assefa, Joel Berniac, Beena Bhatia, Todd Bowser, Jason Burdette, Roger Frechette, Lynne Garrity-Ryan, Mark Grier, Laura Honeyman, Mohamed Ismail, Sean Johnston, Alexandre Kaoukhov, Oak Kim, Courtney Kirsch, Evan Loh, Amy Manley, Gabriel Medjanis, Paul McGovern, Mark Nelson, Kwasi Ohemeng, Farzaneh Seyedi, Judith Steenbergen, S. Ken Tanaka, Evangelos Tzanis, Atul Verma, Tadeusz Warchol

    Pharmacyclics, LLC, An Abbvie Company

    The American Chemical Society acknowledges a group of researchers affiliated with Pharmacyclics, LLC, an AbbVie Company, whose research led to the development of Ibrutinib, marketed as IMBRUVICA®.

    IMBRUVICA® (ibrutinib) is a first-in-class, oral, once-daily therapy that mainly works by inhibiting a protein called Bruton's tyrosine kinase (BTK). BTK is a key signaling molecule in the B-cell receptor signaling complex that plays an important role in the survival and spread of malignant B-cells.

    IMBRUVICA® is FDA-approved in six distinct diseases: chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenström’s macroglobulinemia (WM), along with previously treated mantle cell lymphoma (MCL), previously treated marginal zone lymphoma (MZL), and previously treated chronic graft-versus-host disease (cGVHD).

    Awardees: Yunbiao Chen, Erick Goldman, Lee Honigberg, Wenchen Luo, Yuelie Lu, Rex Maimait, James Palmer, Zhengying Pan, Mark Smyth, Paul Sprengeler, Erik Verner, David Wirth

    PPG Industries

    The American Chemical Society honors a group of scientists from PPG, whose research led to the development of the B1:B2™ Compact Process, an automotive paint system that eliminates several steps in the traditional coating process.

    Awardees: David Aiken, Marvis Hartman, Leigh-Ann Humbert, Wolfgang Klaeger, Dennis Simpson

  • 2018 Recipients


    The American Chemical Society honors scientists from AstraZeneca for TAGRISSOTM (osimertinib), a novel, targeted treatment for patients with EGFR-mutated non-small cell lung cancer. Osimertinib is approved in more than 75 countries.

    Awardees: Sam Butterworth, Ray Finlay, Richard Ward, Michael Waring


    The American Chemical Society honors scientists from DuPont for inventing Solamet® PV17x, the metallization paste that pioneered the use of lead tellurite chemistry, a game changer in the solar energy industry.

    Awardees: Alan Carroll, Kenneth Hang, Brian Laughlin, Kurt Mikeska, Charlie Torardi, Paul VerNooy


    The American Chemical Society honors scientists from Pfizer for the discovery and development of Inlyta® (axitinib), a standard of care for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.

    Awardees: Steve Bender, John Braganza, Anthony Campeta, Brian Chekal, Stephan Cripps, Michael R. Collins, Steven Guinness, Robert Kania, Michele McTigue, Cindy Palmer, Robert Singer, Jayaram Srirangam, Mike Varney, Shu Yu, Scott Zook

    Seattle Genetics

    The American Chemical Society honors scientists from Seattle Genetics for the discovery and development of ADCETRIS® (brentuximab vedotin), an antibody-drug conjugate (ADC) that contains the highly potent synthetic drug, monomethylauristatin E, attached to an anti-CD30 antibody through a dipeptide linker.

    Awardees: Tim Bovee, Svetlana Doronina, Brian Mendelsohn, Peter Senter, Clay Siegall, Brian Toki

  • 2017 Recipients

    Bristol-Myers Squibb

    The American Chemical Society honors scientists from Bristol-Myers Squibb for the contributions to the discovery of the combination of the pioneering hepatitis C virus (HCV) NS5A inhibitor, Daklinza® (daclatasvir), and the acylsulfonamide-containing HCV NS3 protease inhibitor, Sunvepra TM (asunaprevir), which together demonstrated for the first time that HCV infection could be cured with only direct-acting antiviral agents.

    Awardees: Makonen Belema, Min Gao, Andrew Good, Lawrence Hamann, Fiona McPhee, Nicholas Meanwell, Van Nguyen, Paul Scola, Lawrence Snyder, Li-Qiang Sun, Alan Xiangdong Wang

    Corning Incorporated

    The American Chemical Society honors scientists from Corning Incorporated for inventing a technology which would enable Corning’s ClearCurve® bend-insensitive optical fibers.

    Awardees: Dana Bookbinder, Ming-Jun Li, Pushkar Tandon

    The Dow Chemical Company

    The American Chemical Society honors The Dow Chemical Company for the development of pre-composite polymers that enable greener and higher performing architectural house paints.

    Awardees: Linda Adamson, James Bardman, Kebedeh Beshah, Marie Bleuzen, James Bohling, Ward Brown, Stan Brownell, Michael Clark, Jr., Beth Cooper, Steven Edwards, David Fasano, Catherine Finegan, John Hook, Melinda Keefe, Al Maurice, Ozzie Moore Pressley, William Rohrbach, and Wei Zhang

    DuPont Crop Protection

    The American Chemical Society honors scientists from DuPont Crop Protection for the discovery of DuPont™ Zorvec ®, the first member of a novel class of fungicides to control diseases caused by oomycete pathogens.      

    Awardees: John Andreassi, Mary Ann Hanagan, Lisa Hoffman, Robert Pasteris, and Jim Sweigard


    The American Chemical Society honors scientists from Genentech for the discovery and development of ERIVEDGE® (vismodegib), the first medicine to be approved for the treatment of metastatic or locally advanced basal cell carcinoma.

    Awardees: Remy Angelaud, Georgette Castanedo, Janet Gunzner-Toste, Michael Koehler, James Marsters, Kirk Robarge, Scott Savage, Dan Sutherlin, Vickie Tsui, and Shumei Wang


    The American Chemical Society honors scientists from Merck for the invention of ZEPATIER®, a once-daily, fixed-dose combination tablet containing the NS5A inhibitor elbasvir and the NS3/4a protease inhibitor grazoprevir for the treatment of chronic Hepatitis C Virus infection.

    Awardees: Craig Coburn, Steven Harper, Daria Hazuda, Katharine Holloway, Bin Hu, Nigel Liverton, John McCauley, Craig McKelvey, Mark McLaughlin, Peter Meinke, Michael Rudd, Vincenzo Summa, Feng Xu, Bin Zhong, Ping Zhuang

  • 2016 Recipients

    GlaxoSmithKline and Shionog

    TIVICAY® (dolutegravir) for the treatment of HIV-1

    Awardees: Brian Johns (GSK) and Takashi Kawasuji (Shionogi)


    HFO-1234yf, a non-ozone-depleting and low-global-warming-potential hydrofluoro-olefin refrigerant for mobile air conditioning systems

    Awardees: Nacer Achaichia, Amy Jones, Hang Pham, Robert Richard, Rajiv Singh, Harry Tung, Ron Vogl

    Honeywell UOP

    Honeywell Green Jet Fuel™

    Awardees: Chad Cavan, Ralph Davis, Donald Eizenga, Daniel Ellig, Stanley Frey, Tom Kalnes, Michael McCall, Hieu (Sunny) Nguyen, James Wexler, Randall Williams


    IBRANCE® (palbociclib) for the treatment of metastatic breast cancer

    Awardees: Mark Barvian, R. John Booth, Brian Chekal, Nga Do, Shengquan Duan, David Erdman, Nathan Ide, Kyle Leeman, Rong Li, Mark Maloney, Jade Nelson, John Quin, III, Joseph Repine, Derek Sheehan, Karen Sutherland, Peter Toogood, Scott VanderWel, Brian Weekley, Weili Yu, Hairong Zhou

  • 2015 Recipients

    Bristol-Myers Squibb

    For the discovery of ELIQUIS® (apixaban), a novel oral anticoagulant therapy used most often in patients with atrial fibrillation for whom the risks of stroke, bleeding and death are significantly lower than the decades long standard of care.

    Awardees: Donald Pinto, Patrick Lam, Mimi Quan, Michael Orwat, Robert Knabb, Pancras Wong

    Celgene Corporation

    For the discovery and development of POMALYST®(pomalidomide), a drug that is changing the treatment paradigm for cancer patients stricken with multiple myeloma.

    George Muller and Roger Shen-Chu

    The Dow Chemical Company

    For the development of INSITE™, a revolutionary technology that made possible highly-tailored materials bridging the properties of plastic and rubber.

    David Devore, Morris Edmonson, Pradeep Jain, George Knight, Brian Kolthammer, Shih-Yaw Lai, Robert LaPointe, David Neithamer, Peter Nickias, Jasson Patton, Robert Rosen, James Stevens, Francis Timmers, Daniel VanderLende, David Wilson

    Eastman Chemical Company

    For the development of Eastman Tritan™ copolyester, a new family of engineering plastics that are clear, tough, chemical-resistant, and free of estrogenic and androgenic activity.

    Benjamin Barton, Emmett Crawford, Ted Germroth, Christopher Killian, Anthony Messina, David Porter

    Gilead Sciences, Inc.

    For the development of HARVONI®, the first single-tablet regimen for the treatment of chronic hepatitis C, a disease that affects more than 3 million Americans.

    Benjamin Graetz, Bruce Ross, Michael Sofia, Robert Scott, Erik Mogalian, Rowchanak Pakdaman, Cheng Yong Yang, John Link

    Pfizer Inc.

    For the development of XELJANZ® (tofacitinib citrate), a revolutionary oral therapy for the treatment of rheumatoid arthritis, which affects nearly 24 million people worldwide.

    Awardees: Mark Flanagan, Michael Munchhof, Todd Blumenkopf, Paul Changelian, Matthew Brown, Chakrapani Subramanyam, Elizabeth Kudlacz, Eileen Elliott, Michael Fisher, Douglas Ball, Willian Brissette, Frank Busch, Robert Dugger, Sally Gut-Ruggeri, Frank Urban, Rajappa Vaidyanathan

  • 2014 Recipients

    • Asahi Kasei's Takashi Adachi, Muneaki Aminaka, Isaburo Fukawa, Shinsuke Fukuoka, Kazumi Hasegawa, Mamoru Kawamura, Shigenori Konno, Kazuhiko Matsuzaki, Manabu Oishi, Masahiro Tojo, Akio Yamaguchi, Kazuharu Yasuda, and Haruyuki Yoneda whose determination led to the world’s first non-phosgene aromatic polycarbonate (PC) from carbon dioxide that has been manufactured since 2002.
    • Bristol-Myers Squibb's Scott Biller, John Dickson, Michael Lawrence, David Magnin, Michael Poss, Jeffrey Robl, and Joseph Tino for the discovery of Lomitapide (Juxtapid®), a novel inhibitor of microsomal triglyceride transfer protein (MTP) to treat homozygous familial hypercholesterolemia.
    • The Dow Chemical Company's Timothy Adams, Suzanne Coley, Vipul Jain, Doris Kang, Amy Kwok, Owendi Ongayi, Edward Pavelchek, James Thackeray, Peter Trefonas, Gerald Wayton, Sabrina Wong, Jeong Yun Yu and Anthony Zampini for the development of Dow AR™ Fast Etch Organic Bottom Antireflectant Coatings for the Enablement of High Resolution Microlithography in Advanced Integrated Circuit Manufacture.
    • Pfizer's (formerly Wyeth) Magid Abou-Gharbia, Terrance Andree, G.E. Morris Husbands, Eric A. Muth, and John Yardley for developing Effexor®, a novel treatment for major depressive disorder.
    • The Procter & Gamble Company's Lori Bacca, Arif Baig, Bill Glandorf, Tao He, Iain Hughes, Satya Majeti, Ross Strand, Xiaoli Wang, and Donald White, who are the innovators behind the Crest Pro-Health innovation.
  • 2013 Recipients

    Heroes of Chemistry whose work has led to the welfare and progress of humanity

    • DuPont's Daniel Cordova, John Freudenberger, George Lahm, Thomas Selby, and Thomas Stevenson for developing DuPontTM Rynaxypyr®, the first anthranilic diamide insect control product.
    • Merck & Co., Inc.’s David Askin, Guy Humphrey, Ralph Laufer, Peter Maligres, Michael Rowley, Vincenzo Summa, Joseph Vacca, John Wai, and Steven Young for developing Isentress®, the first integrase inhibitor approved for use in HIV infected patients.
    • Pfizer, Inc.'s J. Jean Cui, Pei-Pei Kung, Mason Pairish, Hong Shen and Michelle Tran-Dubé for developing Crizotinib, a revolutionary non-small-cell lung cancer pharmaceutical agent.
    • Vertex Pharmaceutical’s Vijayalaksmi Arumugam, Brian Bear, Peter Grootenhuis, Sabine Hadida, Anna Hazlewood, Adam Looker, Jason McCartney, Bobbianna Neubert-Langille, Michael Ryan, David Willcox, Zhifeng Ye and Jinglan Zhou for the development of KalydecoTM, the first medicine to treat the underlying cause of cystic fibrosis.
  • 2012 Recipients

    Heroes of Chemistry whose work has led to the welfare and progress of humanity

    • Arkema's Georg Lindner, Connie Lo, Clem McKown, Jing Ming Mai, Jeremy Nihart, Dave Russo, Ryan Smith and Jeff Stricker of Arkema, for the scientific discovery, technical development, and commercial implementation of Atmospheric Pressure Chemical Vapor Deposition technology in the production of high performance window glass.
    • Merck & Co., Inc.’s Ashok Arasappan, Frank Bennett, Stéphane Bogen, F. George Njoroge and Srikanth Venkatraman for the discovery and development of VictrelisTM, a first-in-class treatment for the Hepatitis C virus.
    • Novartis Institutes of Biomedical Research's Werner Breitenstein, Gabriele Fendrich, Sandra Jacob and Paul Manley for the discovery and development of Tasigna®, a leading treatment for Chronic Myeloid Leukemia.
  • 2011 Recipients

    Speaker: Dr. Greg Allgood, Children's Safe Drinking Water Program

    • DuPont's George Trainor for the invention of dye-terminating DNA sequencing.
    • AstraZeneca's Andy Barker and Keith Gibson for the discovery and development of Iressa, a targeted anti-lung cancer drug.
  • 2010 Recipients

    Speaker: Mark J. Plotkin, Ethnobotanist and Author

    • Merck & Co., Inc.’s Joseph Armstrong, Nancy Thornberry and Ann Weber for the discovery and development of Januvia.
    • Pfizer Inc.’s Jotham Coe and Brian O’Neill for the discovery and development of Varenicline (Chantix).
  • 2009 Recipients

    Speaker: John LaMattina, Retired Pharmaceutical Executive

    • 3M Company’s Sumita B. Mitra for the development of Filtek™ Supreme Universal Restorative.
    • The Dow Chemical Company’s John E. Cadotte, and William E. Mickols for the invention of High Performance Reverse Osmosis Membranes.
    • Novartis Institutes for Biomedical Research’s Nissim Claude Cohen, Richard Göschke, Peter Herold, Robert Mah, Jürgen Maibaum, Joseph Rahuel, Vittorio Rasetti, Pascal Rigollier, Heinrich Rueeger, Walter Schilling, Stefan Stutz, and Yasuchika Yamaguchi for the development of Tekturna® (Aliskiren).
  • 2008 Recipients

    Speaker: Mae Jemison, Astronaut and Physician

    • ExxonMobil Research and Engineering Company’s Michael Kerby, Ernie Lewis, Stephen McCarthy, Sabato Miseo, Kenneth Riley and Stuart Soled and Albemarle Catalysts Company’s M.B. Cerfontain, Sonja Eijsbouts, Hans W. Homan Free, Bob Leliveld, Bob Oogjen and Frans L. Plantenga, for the development of NEBULA™ Catalyst.
    • Genentech, Inc.’s Bruce Roth for creating Lipitor® (Pfizer Inc).
    • GlaxoSmithKline Pharmaceutical’s Karen Lackey for constructing Tykerb® (lapatinib).
    • Pfizer Inc’s Duncan Armour, Blanda Stammen, Anthony Wood and David Price for the development of Maraviroc.
    • Wyeth Research’s Magid Abou-Gharbia, Jerauld Skotnicki, James Gibbons, Ker Yu, Warren Chew, Joseph Camardo and Gary Dukart for their inception of Torisel®.
  • 2007 Recipients

    Speaker: Dean Kamen, Inventor and Entrepreneur

    • Chevron Phillips Chemical Company's Ronald D. Knudsen for the development of Selective 1-Hexene (S1H) Process.
    • E.I. DuPont de Nemours and Company's Catherine H. Babowicz Charles E. Nakamura and Tate & Lyle’s Dennis M. Adkesson along with Genecor’s Gregory M. Whited for the development of Bio-PDO™ .
    • ExxonMobil Research and Engineering's Jeevan S. Abichandani, Jeffrey S. Beck, Arthur Chester, Thomas Degnan, Jocelyn Kowalski, Sharon McCullen and David Olson for developing the PxMax sm Process.
    • Novartis Institutes for Biomedical Research's Pierre Acklin (Deceased), Peter Bühlmayer, Bernard Faller, René Lattmann, Hanspeter Nick, Carsten Spanka and Paul Zbinden for the development of Exjade®.
    • Pfizer's Harry R. Howard, Jr., John A. Lowe III and Arthur A. Nagel (Retired) for the development of Geodon®.
  • 2006 Recipients

    Heroes of Chemistry whose work has led to the welfare and progress of humanity

    • ATMI’s Jose Arno, Donald Carruthers and Edward Sturm for the development of SDS (Safe Delivery System®).
    • E.I. DuPont de Nemours and Co.’s Donald B. Bivens, Mark B. Shiflett and Akimitchi Yokozecki for the development and invention of Hydrofluorocarbon Refrigerant Blends.
    • Eli Lilly and Company’s Homer Pearce (retired), Chuan Shih and Princeton University’s Edward C. Taylor for the development of Alimta®.
    • Merck & Co., Inc.’s James M. Balkovec, David L. Hughes and Robert E. Schwartz for the development of CANCIDAS® (caspofungin acetate)IV.
    • Rohm and Haas Company’s Guy Clamen, Richard Dobrowolski, Griffin Gappert, William Finch, Hal C. Morris, Paul Nedwick, Xun Tang and Barry Weinstein for the development of AquaSet™.
    • Wyeth’s Evelyn J. Ellis-Grosse, Evan Loh, Phaik-Eng Sum and Raymond Testa for the development of Tygacil®.
  • 2005 Recipients

    Heroes of Chemistry whose work has led to the welfare and progress of humanity

    • Colgate-Palmolive Company’s Abdul Gaffar for the development of Colgate Total®.
    • ExxonMobil Corporation’s Garland B. Brignac, Bruce R. Cook, Richard A. Demmin, John P. Greeley, Thomas R. Halbert, Jeffrey L. Kaufman, Mark Lapinski, Steve Mayo, Craig A. McKnight and Kenneth L. Riley for their development of SCANfining and Second-Generation SCANfining II Processes.
    • IBM’s Hiroshi Ito and C. Grant Willson for the development of Chemically-Amplified Photoresist Materials.
    • Johnson & Johnson Pharmaceutical Research and Development’s Ludo Kennis for discovering RISPERDAL® (risperidone).
    • Novartis Institutes for Biomedical Research’s Jürg Zimmermann, Peter Traxler, Peter Graf and Ulrike Pfaar for developing GLEEVEC® (imatinib mesylate).
  • 2004 Recipients

    Heroes of Chemistry who have improved human health and well-being through biotechnology products that involve chemistry or biochemistry contributions

    • 3M’s John F. Gerster and Richard L. Miller for the creation of Aldara™ (imiquimod) QLT, Inc.’s David H. Dolphin for the development of Visudyne®.
    • Schering-Plough Corporation’s Duane A. Burnett, John W. Clader, Brian A. McKittrick, Stuart B. Rosenblum and Sundeep Dugar for the discovery of Zetia® (ezetimibe).
    • Wyeth Pharmaceutical’s George A. Ellestad, Philip R. Hamann, Janis Upeslacis, Parimal R. Desai and Donald R. Miller for the development of Mylotarg® (gemtuzumab ozogamici).
  • 2003 Recipients

    Heroes of Chemistry who have improved children’s health and wellness through chemistry

    • Abbott Laboratories’ Hing L. Sham, Daniel W. Norbeck and Dale J. Kempf for the development of KALETRA® (lopinavir/ritonavir).
    • Merck & Co., Inc.’s Robert N. Young, Robert J. Zamboni and Marc Labelle (former colleague) for the discovery of Singulair® (montelukast sodium).
    • Pfizer Inc’s Gerhard Satzinger, Johannes H. Hartenstein and James R. Zeller for the discovery and development of Neurontin® (gabapentin).
    • Wyeth Pharmaceutical’s Ronald J. Eby, Maya Koster, Chia-Lung Hsieh (deceased), Velupillai Puvanesarajah, Steven H. Doares, Bradley E. Kosiba, Dan J. Speelman and Kent D. Murphy for the discovery of Prevnar® (Diphtheria CRM197 Protein).
  • 2002 Recipients

    Heroes of Chemistry who have protected and secured our world through chemistry

    • DSM’s Koos Mencke, René Steeman and Jean Beugels for developing processes, materials and products based on a Polyethylene Fiber.
    • DuPont’s
      - Richard W. Rees for the discovery of Ionomer Resins.
      - Mark A. Jensen, W. Mark Barbour, George Tice, Jr. and Susan Y. Tseng for developing a Laboratory Screening System.
    • Solutia Inc.’s James R. Moran for developing a Polyvinyl Butyral Interlayer.
  • 2000 Recipients

    Heroes of Chemistry who have promoted global human welfare in:

    Energy & the Environment

    • Calgon Carbon Corporation’s K. Ramen Venkatesh for his research and development of the ISEP® technology.
    • Energy Conversion Devices, Inc.’s Stanford R. Ovshinsky and Iris M. Ovshinsky for their contributions in developing Ovonic NiMH.


    • Bristol-Myers Squibb’s Miguel A. Ondetti and David W. Cushman, for their discovery of Capoten®.
    • Novartis Pharmaceuticals AG’s Wilfried Bauer and Trevor Petcher for the creation of Sandostatin®.
    • Novartis Pharmaceuticals AG’s Peter Bühlmayer, Franz Ostermayer, Tibur Schmidlin, Pascal Furet, Walter Fuhrer, Peter Herold, Bruno Kamber, Hans Kuehnis, René Lattmann, Thomas Leutert, Alfred Sallmann and Paul Zbinden for their team development of Diovan®.
    • Pfizer Inc’s Arthur E. Girard and Gene Michael Bright and PLIVA d.d. of Croatia’s Slobodan Djokic and Gabrijela Kobrehel for their discovery of Zithromax® (azithromycin).
    • The Procter & Gamble Company’s M. David Francis for the development of Osteoscan®, Didronel® (etidronate) and Advanced Formula Crest® Toothpaste.
    • The R.W. Johnson Pharmaceutical Research Institute’s Bruce E. Maryanoff, for the development of Topamax® (topirama).

    Nutrition & Agriculture

    • BASF Aktiengesellschaft’s Hubert Sauter for his significant contributions towards the discovery and development of Strobilurins.
    • The Procter & Gamble Company’s Haile Mehansho for discovering Margarine™, Choco Milk™ and Nurtri-Delight™.

    Shelter & Global Communication

    • The Dow Chemical Company’s L. C. Rubens for his contributions to the discovery and commercialization of Polymeric Foam.
    • Xerox Corporation’s Damodar Pai, John Yanus and Milan Stolka for their significant contributions towards the first Organic Photoreceptor Device.
  • 1999 Recipients

    Heroes of Chemistry with innovations in the food and agriculture fields

    • American Cyanamid Co.’s Marinus Los for the discovery of the Imidazolinone Class of Herbicides.
    • Bayer Corp.’s Martin Gruss, Hans-Ferdinand Muisers, Kozo Shiokawa, Reinhard Lantzsch, Achim Noack, Rudiger Altmann, Konrad Scholz, Akira Imokawa, Shinichi Tsuboi, Gary J. Aagesen, Val E. Clay and Francis T. McNamara for the development of Imidacloprid (Admire®, Confidor®, Connect®, Evidence®, Leverage®, Muralla®, Provado®, Trimax®).
    • Dow AgroSciences, LLC’s Etcyl Blair, Cleve Goring, Howard Johnston, F. John Peskett, Ray Rigterink, Art Sexton and Bill Taplin for the development and commercialization of Pyridine-Based Products.
    • DuPont’s George Levitt for the discovery of the Sulfonylurea Class of Herbicides.
    • Hercules, Inc.’s Timothy C. Gerrish, Lawrence Carosino, Kenneth L. Chambliss and Pong-Kuen P. Kuo for the development of Slendid™.
    • National Starch and Chemical Co.’s Carlyle Gordon Caldwell for the advancement of Starch Chemistry.
    • Pfizer Inc’s Kelvin S. Holdom, Stephen P. Gibson, Alexander C. Goudie and Edmund W. Hafner for devoloping Doramectin.
    • The Procter & Gamble Co.’s Patrick Corrigan for the design process and conditions for Olean®.
  • 1998 Recipients

    Heroes of Chemistry with petrochemical innovations in the automotive field

    • Ashland Chemical Co.’s Dennis Fisher for the development of Phase Beta™ and HIPPI ™ sheet molding compounds.
    • Exxon Chemical / PARAMINS’s Gary Ver Strate, Ricardo Bloch, Mark Struglinskki, John Johnston and Roger West for the invention of Lubricant Viscosity Modifier.
    • Mobil Technology Co.’s Mike Ramage for the creation of Mobil 1® Series.
    • Phillips Petroleum’s
      - J. Paul Hogan and Robert L. Banks for the development of High Density Polyethylene and Polypropylene.
      - Marvin M. Johnson for the creation of Phillips Petroleum.
    • Texaco Inc.’s Mary E. Dery, Sheldon Herbstman, Benjamin J. Kaufman, Jack M. Larkin, Joseph M. Russo and Wei Yang Su for the development of CleanSystem-3 Gasoline Additive Team.
    • Universal Oil Products (UOP)’s Alan P. Cohen, Sue Correll, Peter Coughlin and Jack Hurst for the development of XH-7 Molecular Sieves.
  • 1997 Recipients

    Heroes of Chemistry with environmental safety, protection and technologies

    • 3M’s Scott Thomas, John C. Hansen, Daniel Vitcak, Thomas Herzberg, John Owens, Hideto Yanome, Paul Lieder, Frank Klink, Richard Minday, Richard Flynn and Dean S. Milbrath for their development of Hydrofluoroethers.
    • AlliedSignal’s Russell W. Johnson, Rajat Basu, Michael Hughes, Addison Smith, Harry Tung and David Wilson for the development of the Allied Signal EnergetX™ Process.
    • DuPont’s Walter Cicha, Andrew Degraff Jr., R. Bertrum Diemer, Jr., Kang Lin, Leo Manzer, Brandley Martin, Paula Solomon, Stan Ziemecki and Charles Bellini for the development of an Innovative Replacement Catalyst.
    • Eastman Kodak’s Sheridan Vincent for the development of Process RA-4.
    • IBM’s Jeff Zimmerman for his contributions in the development of a No-Clean Flux Solder Process.
    • Phillips Petroleum’s Elizabeth Benham, Michael Smith and Max McDaniel for their work in creating Phillips Low Density Linear Polyethylene.
    • Stepan’s Warren Kaplan for the development of a Production Process for Polyurethane Rigid Foams.
    • Union Camp’s Bruce Griggs, Spencer Eachus, Thomas Gandek, Michael Pikulin and David White for the development of the Union Camp C-Free Pulp Bleaching Process.
  • 1996 Recipients

    Heroes of Chemistry with innovations for the space industry

    • Air Products and Chemicals, Inc.’s
      - Lee Gaumer for the development of Qualities of Liquid Hydrogen.
      - Edward Kiczek and Paul Mattiola for the development of the Phase Flow Meter Project.
      - Venkat Raman for the development of Futuristic uses for Hydrogen.
    • Albemarle’s C. Ted Bounds, Larry East, Clarice Hanusz, Wayne C. Lotz and William Wolvert on for the development of Artificial March.
    • Alliant Tech System’s Paul Miller for the development of Super Absorbent Materials.
    • Eastman Kodak’s Richard Wien, Jr. for his work on Image Quality and Customized Digital Imaging System.
    • General Magnaplate’s Charles P. Covino for the development of Tuffram and HI-T-LUBE®.
    • Hamilton Standard’s Philip J. Birbara and Timothy A. Nalette for the development of Regenerable Carbon Dioxide Sorbent.
    • Inorganic Coatings, Inc.’s Scott Armstrong for the creation of IC 531.
    • Lawrence Livermore National Laboratories’ Leroy Chiao for the development of Graphite Fiber/Epoxy Composite Material.
    • Morton International’s Michael Pickering for the development of Silicon Carbide Fiber.
    • NASA Langley Research Center’s Henry G. Reichle Jr. for the development of Tropospheric Photochemical Modeling.
    • PCP, Inc.’s Martin J. Cohen for the development of Ion Mobility Spectrometer.
    • System & Process Engineering Corp.’s Robert C. Chen for his work on Chemical Biological Sensors.
    • Thiokol Corp.’s
      - Greg L. Anderson for the development of Silane Adhesion Promoter.
      - Roger R. Hendrickson for the development of Solid Propellants.
      - Russel A. Crook, Michael W. Lesley and James Sinclair for the development of Ozone Depleting Compounds.
    • TRW, Inc.’s Tito Serafini for the development of PMR- 15.0.